| Product NDC: | 50242-140 | 
| Proprietary Name: | ERIVEDGE | 
| Non Proprietary Name: | vismodegib | 
| Active Ingredient(s): | 150 mg/1 & nbsp; vismodegib | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 50242-140 | 
| Labeler Name: | Genentech, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA203388 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20120130 | 
| Package NDC: | 50242-140-01 | 
| Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (50242-140-01) > 28 CAPSULE in 1 BOTTLE, PLASTIC | 
| NDC Code | 50242-140-01 | 
| Proprietary Name | ERIVEDGE | 
| Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (50242-140-01) > 28 CAPSULE in 1 BOTTLE, PLASTIC | 
| Product NDC | 50242-140 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | vismodegib | 
| Dosage Form Name | CAPSULE | 
| Route Name | ORAL | 
| Start Marketing Date | 20120130 | 
| Marketing Category Name | NDA | 
| Labeler Name | Genentech, Inc. | 
| Substance Name | VISMODEGIB | 
| Strength Number | 150 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Hedgehog Pathway Inhibitor [EPC],Smoothened Receptor Antagonists [MoA] |